Will the CDC weaken vaccine recommendation against _____ for children and adolescents in 2026?
💡 What the odds say
Most likely: MMR at about a 23% chance.
The field is moderately open: the top two candidates (MMR at 23%, Polio at 21%) together hold only 44%, and no other option exceeds 5%, meaning a late surge by a different vaccine or a reversal is plausible. The single biggest recent shift was the January 2026 overhaul of the childhood vaccine schedule by HHS Secretary RFK Jr., which downgraded advice for multiple shots and triggered lawsuits (Politico, Jan 5; CNN, Jan 14).
What's driving it
- • RFK Jr.'s appointment as Health Secretary and his January 2026 overhaul of the childhood vaccine schedule, which downgraded recommendations for flu, meningitis, and other shots, directly raised the probability that the CDC will weaken recommendations for specific vaccines (Politico, Jan 5).
- • Medical groups sued in January 2026 to block the new CDC vaccine recommendations, creating legal uncertainty that could either slow or accelerate further weakening depending on court outcomes (CNN, Jan 14).
- • CDC staff were reportedly 'blindsided' by the unilateral overhaul, suggesting internal resistance that may temper the pace of future changes (Washington Post, Jan 7).
Why the front-runners lead
- • MMR leads because RFK Jr. has a long history of questioning the MMR vaccine's safety, and the January overhaul already signaled a willingness to align U.S. schedules with Denmark's, which has different MMR recommendations (NBC News, Jan 5).
- • Polio leads because it is a high-profile childhood vaccine, and the January downgrades for other shots set a precedent that polio could be next, especially given the administration's stated goal of reducing the number of recommended vaccines (U.S. News, Jun 26).
Why it's still open
- • The field is open because the January overhaul downgraded advice for flu and meningitis, not MMR or polio, meaning those vaccines could still emerge as the actual target if the administration prioritizes them (Politico, Jan 5).
- • Legal challenges from medical groups (CNN, Jan 14) and internal CDC resistance (Washington Post, Jan 7) could block or delay any weakening, making it possible that no vaccine recommendation is changed in 2026, which would keep the field wide.
What to watch
- • A federal court ruling on the medical groups' lawsuit (filed Jan 14) could either uphold the January overhaul (raising odds for further weakening) or strike it down (lowering odds), likely within months.
- • The CDC's Advisory Committee on Immunization Practices (ACIP) meetings, typically scheduled quarterly, could produce new recommendations or public statements that clarify which vaccines are under review, shifting odds toward the named vaccine.
AI-generated · grounded in recent news + odds · informational only, not advice. Verify on the source platform.
Data from Futuur’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Resolved by Futuur per each question's rules. Futuur runs both play- and real-money sides — we show the real-money (crypto) price.
ⓘ A market settles under its own written rules, which can lag what looks decided in the news — so the price may not move to 100% the moment an outcome seems obvious.
View the official rules on Futuur ↗Related markets
Democratic Presidential Nominee 2028
The field is virtually nonexistent: only two candidates register at 1% each, and no one has broken 5%, making this the most open Democratic nomination race in modern history. The single biggest recent shift is the DNC's decision to put South Carolina first in the 2028 primary calendar (Axios, Jul 25), which could reshape candidate strategies and favor a different type of contender.
2 outcomes
Fed Decision in July?
Despite oil surging near $100 and resurfacing inflation fears, the market is overwhelmingly pricing in no rate change at the July FOMC meeting, suggesting traders see the Fed as willing to look through energy-driven price pressures for now.
5 outcomes
Next General Election - Most Seats
The field is moderately concentrated with Labour leading at 36%, but Reform UK and Conservative are close; the biggest recent shift is Reform UK overtaking the Conservatives for second place, as seen in the stated odds, though no headline directly explains this.
9 outcomes
Will Trump announce he is running for President in the 2028 election?
The market surged 12 points in 24 hours after Trump's ambiguous remarks at the White House Correspondents' Dinner were interpreted by some as a formal declaration of a 2028 run, despite the clear constitutional bar on a third term.
Yes ≈ 65% chance
Republican Presidential Nominee 2028
The Republican nomination field is exceptionally fragmented, with no candidate above 5% and the top three sum to just 1% — a sign that the race is truly wide open and still in its earliest jockeying phase, despite a recent poll placing Senator JD Vance near the top of a generic primary ballot (USA Today, Jul 23).
2 outcomes
Republican Presidential Nominee 2028
The field is highly concentrated at the top, with Kennedy and Vance combining for 92% of the odds, but the real story is Kennedy's surge to 49%—a position that lacks any clear recent headline catalyst, as the provided headlines focus on Democratic odds, Loomer's Ukraine meeting, and a Buttigieg-Vance poll, not Kennedy.
128 outcomes